Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States.
作者信息
Shrestha Sourya, Parriott Andrea, Menzies Nicolas A, Shete Priya B, Hill Andrew N, Marks Suzanne M, Dowdy David W
机构信息
Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland.
University of California San Francisco San Francisco, California.
出版信息
Ann Am Thorac Soc. 2020 Dec;17(12):1639-1642. doi: 10.1513/AnnalsATS.202005-574RL.
Abstract
摘要
相似文献
1
Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States.在美国使用六周每日利福喷汀方案治疗潜伏性结核感染的估计人群水平影响。
Ann Am Thorac Soc. 2020 Dec;17(12):1639-1642. doi: 10.1513/AnnalsATS.202005-574RL.
2
Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.潜伏性结核感染的治疗完成情况：一项回顾性队列研究，比较9个月异烟肼、4个月利福平以及3个月异烟肼和利福喷汀的治疗效果。
BMC Infect Dis. 2017 Feb 14;17(1):146. doi: 10.1186/s12879-017-2245-8.
3
Treatment of latent tuberculosis infection.潜伏结核感染的治疗。
Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20.
4
Analysis of Severe Adverse Events Reported Among Patients Receiving Isoniazid-Rifapentine Treatment for Latent Mycobacterium tuberculosis Infection-United States, 2012-2016.2012-2016 年美国利福平异烟肼治疗潜伏性结核分枝杆菌感染患者严重不良事件报告分析。
Clin Infect Dis. 2020 Dec 3;71(9):2502-2505. doi: 10.1093/cid/ciaa286.
5
Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.12剂方案对潜伏性结核感染的影响：台湾地区的治疗完成率及成本效益
Medicine (Baltimore). 2016 Aug;95(34):e4126. doi: 10.1097/MD.0000000000004126.
6
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.自我给药与直接观察下的每周一次异烟肼和利福喷汀治疗潜伏性结核感染：一项随机试验。
Ann Intern Med. 2017 Nov 21;167(10):689-697. doi: 10.7326/M17-1150. Epub 2017 Nov 7.
7
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study.利福喷丁单药与联合异烟肼治疗潜伏性结核感染的疗效比较：转化药代动力学-药效学模型研究。
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0170521. doi: 10.1128/AAC.01705-21. Epub 2021 Oct 4.
8
SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.SIRCLE：自我给药的短程异烟肼和利福喷汀用于具有成本效益的潜伏性结核根除的随机对照成本比较
Intern Med J. 2017 Dec;47(12):1433-1436. doi: 10.1111/imj.13601.
9
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.儿童和青少年结核病预防治疗：利福喷汀与异烟肼联合用药3个月、12剂方案的随机临床试验
JAMA Pediatr. 2015 Mar;169(3):247-55. doi: 10.1001/jamapediatrics.2014.3158.
10
Evaluation of 3 Months of Once-Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection.评价利福喷丁和异烟肼治疗潜伏性结核病感染的 3 个月疗程。
Ann Pharmacother. 2020 May;54(5):457-463. doi: 10.1177/1060028019888855. Epub 2019 Nov 15.
引用本文的文献
1
The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study.美国家庭和国际结核病服务改进对结核病趋势的长期影响：一项数学建模研究。
Lancet Public Health. 2024 Aug;9(8):e573-e582. doi: 10.1016/S2468-2667(24)00150-6.
本文引用的文献
1
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.潜伏结核感染治疗指南：美国国家结核病控制协会和美国疾病预防控制中心 2020 年推荐意见。
MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. doi: 10.15585/mmwr.rr6901a1.
2
Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California.加利福尼亚州结核病流行病学和政策结果的比较建模。
Am J Respir Crit Care Med. 2020 Feb 1;201(3):356-365. doi: 10.1164/rccm.201907-1289OC.
3
Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis.加利福尼亚州、佛罗里达州、纽约州和德克萨斯州州级结核病干预措施的影响和效果：基于模型的分析。
Am J Epidemiol. 2019 Sep 1;188(9):1733-1741. doi: 10.1093/aje/kwz147.
4
Outlook for tuberculosis elimination in California: An individual-based stochastic model.加利福尼亚州消除结核病的前景：基于个体的随机模型。
PLoS One. 2019 Apr 9;14(4):e0214532. doi: 10.1371/journal.pone.0214532. eCollection 2019.
5
Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011-2015.2011-2015 年美国潜伏性结核病感染的局部流行率简易估计。
Emerg Infect Dis. 2018 Oct;24(10):1930-1933. doi: 10.3201/eid2410.180716.
6
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.成人潜伏性结核：利福平治疗 4 个月或异烟肼治疗 9 个月。
N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.
7
Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model.美国消除结核病的前景：传播动力学模型的结果。
Am J Epidemiol. 2018 Sep 1;187(9):2011-2020. doi: 10.1093/aje/kwy094.
8
Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.美国的结核感染情况：2011 - 2012年美国国家健康与营养检查调查的患病率估计
PLoS One. 2015 Nov 4;10(11):e0140881. doi: 10.1371/journal.pone.0140881. eCollection 2015.
9
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.美国治疗潜伏性结核感染 12 剂方案的成本效益分析。
Int J Tuberc Lung Dis. 2013 Dec;17(12):1531-7. doi: 10.5588/ijtld.13.0423.
10
Three months of rifapentine and isoniazid for latent tuberculosis infection.利福喷丁和异烟肼治疗潜伏性结核感染 3 个月。
N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.
Zotero 插件